概括
不准确的临床前科学对公众健康和安全构成重大风险. 确保科学完整性对于维持对药物安全的监管保护至关重要.
科学领域:
- 监管科学 监管科学
- 公共卫生政策 公共卫生政策
- 生物医学研究伦理学
背景情况:
- 不准确,粗鲁或欺诈性的科学对公共健康和安全构成重大威胁.
- 科学错误的来源 (例如,文职人员,技术差,无能,疏忽) 比科学不正确的事实更不重要.
- 当食品和药物管理局 (FDA) 等监管机构不知道科学不准确时,患者的安全网就会受到损害.
研究的目的:
- 强调在临床前试验中科学准确性至关重要.
- 强调依赖错误的科学数据对公共卫生的潜在后果.
- 强调监管监督在保障患者安全方面的作用.
主要方法:
- 分析科学错误在监管环境中的影响.
- 审查不准确的临床前数据对药物批准过程的影响.
- 审查FDA在确保科学证据完整性的作用.
主要成果:
- 无论来源如何,科学不准确性都会破坏保护性监管框架.
- 错误的临床前数据可能导致不安全或无效药物的批准.
- 美国食品和药物管理局对科学有效性的了解对于有效的监管至关重要.
结论:
- 在临床前科学中坚持严格的标准对于公共卫生至关重要.
- 科学报告的透明度和准确性对于监管决策至关重要.
- 强有力的监督是必要的,以防止潜在的危险药物到达患者.
相关概念视频
Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...


